Tango Therapeutics Stock (NASDAQ:TNGX)


ForecastRevenueOwnershipFinancialsChart

Previous Close

$3.85

52W Range

$2.70 - $13.01

50D Avg

$6.53

200D Avg

$8.49

Market Cap

$438.27M

Avg Vol (3M)

$1.76M

Beta

0.88

Div Yield

-

TNGX Company Profile


Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

140

IPO Date

Sep 03, 2020

Website

TNGX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
License Revenue$5.00M$11.00M-
Collaboration Revenue$31.53M$24.86M$26.04M

Fiscal year ends in Dec 23 | Currency in USD

TNGX Financial Summary


Dec 23Dec 22Dec 21
Revenue$36.53M$24.86M$37.04M
Operating Income$-114.17M$-111.07M$-58.19M
Net Income$-101.74M$-108.18M$-58.23M
EBITDA$-114.17M$-111.07M$-58.19M
Basic EPS$-1.08$-1.23$-0.94
Diluted EPS$-1.08$-1.23$-0.94

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison


TickerCompany
PLRXPliant Therapeutics, Inc.
NRIXNurix Therapeutics, Inc.
KYMRKymera Therapeutics, Inc.
ARVNArvinas, Inc.
CGEMCullinan Oncology, Inc.
RVMDRevolution Medicines, Inc. Warrant
FHTXFoghorn Therapeutics Inc.
MLYSMineralys Therapeutics, Inc.
EWTXEdgewise Therapeutics, Inc.
STOKStoke Therapeutics, Inc.
BDTXBlack Diamond Therapeutics, Inc.
RLAYRelay Therapeutics, Inc.
BCELAtreca, Inc.
RLYBRallybio Corporation
TYRATyra Biosciences, Inc.
CNTBConnect Biopharma Holdings Limited
PASGPassage Bio, Inc.
GLUEMonte Rosa Therapeutics, Inc.
XLOXilio Therapeutics, Inc.
THRDThird Harmonic Bio, Inc.
STTKShattuck Labs, Inc.
RAPTRAPT Therapeutics, Inc.